Integrated Cancer Repository for Cancer Research
Eligible age
19–110 yrs
Accepts
All genders
Locations
18 states
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The iCaRe2 is a multi-institutional resource created and maintained by the Fred \& Pamela Buffett Cancer Center to collect and manage standardized, multi-dimensional, longitudinal data and biospecimens on consented adult cancer patients, high-risk individuals, and normal controls. The distinct characteristic of the iCaRe2 is its geographical coverage, with a significant percentage of small and rural hospitals and cancer centers. The iCaRe2 advances comprehensive studies of risk factors of cancer development and progression and enables the design of novel strategies for prevention, screening, early detection and personalized treatment of cancer. Centers with expertise in cancer epidemiology, genetics, biology, early detection, and patient care can collaborate by using the iCaRe2 as a platform for cohort and population studies.
Sponsor: University of Nebraska
You may qualify if…
- ✓ Diagnosis/history of cancer
- ✓ Risk for developing cancer or suspicious clinical findings
- ✓ No history of cancer (normal control registry)
- ✓ Able to provide informed consent
- ✓ 19 years of age or older
- ✓ English or Spanish speaking individuals
You may not qualify if…
- ✕ Unable to provide informed consent because of cognitive impairment
- ✕ Non-English or non-Spanish speaking individuals
Where it's recruiting
Greenwood Village
Manchester
Daytona Beach · DeLand · Orange City · Palm Coast …
Aurora · Yorkville
Fort Wayne
Council Bluffs · Waterloo
Overland Park
Randallstown · Westminster
Holyoke
Aitkin · Brainerd · Duluth · Fergus Falls
Kansas City · Liberty · North Kansas City · Saint Joseph
Bozeman
Source: ClinicalTrials.gov · NCT02012699 · last updated 2026-05-05